journal
https://read.qxmd.com/read/25214817/what-have-novel-imaging-techniques-revealed-about-metabolism-in-the-aging-brain
#21
Ai-Ling Lin, Douglas L Rothman
Brain metabolism declines with age and do so in an accelerated manner in neurodegenerative disorders. Noninvasive neuroimaging techniques have played an important role to identify the metabolic biomarkers in aging brain. Particularly, PET with fluorine-18 ((18)F)-labeled 2-fluoro-2-deoxy-d-glucose tracer and proton magnetic resonance spectroscopy (MRS) have been widely used to monitor changes in brain metabolism over time, identify the risk for Alzheimer's disease (AD) and predict the conversion from mild cognitive impairment to AD...
May 1, 2014: Future Neurology
https://read.qxmd.com/read/25530720/genetic-loci-associated-with-alzheimer-s-disease
#22
Christiane Reitz
The article by Lambert et al. reports the identification of 11 novel susceptibility loci for late-onset Alzheimer's disease. The observations of this study significantly enhance the field since they further disentangle the genetic causes and pathways underlying Alzheimer's disease by identifying novel disease-associated variants clustering in specific pathways. These pathways include APP processing, lipid metabolism, inflammation/immune response, intracellular trafficking/endocytosis, tau metabolism, synaptic function...
March 2014: Future Neurology
https://read.qxmd.com/read/25221437/translating-cerebellar-purkinje-neuron-physiology-to-progress-in-dominantly-inherited-ataxia
#23
Ravi Chopra, Vikram G Shakkottai
The cerebellum is an important structure for accurate control and timing of movement, and Purkinje neurons in the cerebellar cortex are key players in cerebellar motor control. Cerebellar dysfunction can result in ataxia, a disorder characterized by postural instability, gait disturbances and motor incoordination. Cerebellar ataxia is a symptom of a number of conditions, and the emerging evidence that Purkinje neuron dysfunction, in particular, abnormal Purkinje neuron repetitive firing, is a major driver of motor dysfunction in a subset of dominantly inherited ataxias is dicussed...
March 1, 2014: Future Neurology
https://read.qxmd.com/read/25013385/towards-an-understanding-of-neuropsychiatric-manifestations-in-fragile-x-premutation-carriers
#24
JOURNAL ARTICLE
Aaron D Besterman, Scott A Wilke, Tua-Elisabeth Mulligan, Stephen C Allison, Randi Hagerman, Andreea L Seritan, James A Bourgeois
Fragile X-associated disorders (FXD) are a group of disorders caused by expansion of non-coding CGG repeat elements in the fragile X ( FMR1 ) gene. One of these disorders, fragile X syndrome (FXS), is the most common heritable cause of intellectual disability, and is caused by large CGG repeat expansions (>200) resulting in silencing of the FMR1 gene. An increasingly recognized number of neuropsychiatric FXD have recently been identified that are caused by 'premutation' range expansions (55-200). These disorders are characterized by a spectrum of neuropsychiatric manifestations ranging from an increased risk of neurodevelopmental, mood and anxiety disorders to neurodegenerative phenotypes such as the fragile X-associated tremor ataxia syndrome (FXTAS)...
March 2014: Future Neurology
https://read.qxmd.com/read/28845134/parkinson-s-disease-what-role-do-pedunculopontine-nucleus-cholinergic-neurons-play
#25
JOURNAL ARTICLE
Nicolaas I Bohnen, Martijn L T M Müller, William T Dauer, Roger L Albin
No abstract text is available yet for this article.
January 2014: Future Neurology
https://read.qxmd.com/read/26146489/unlocking-truths-of-%C3%AE-secretase-in-alzheimer-s-disease-what-is-the-translational-potential
#26
JOURNAL ARTICLE
Michael S Wolfe
Considerable evidence, particularly from genetics, points to the aggregation-prone amyloid β-peptide as a pathogenic entity in Alzheimer's disease. Hence, the proteases that produce this peptide from its precursor protein have been prime targets for the development of potential therapeutics. One of these proteases, γ-secretase, has been a particular focus. Many inhibitors and modulators of this membrane-embedded protease complex have been identified, with some brought into late-stage clinical trials, where they have spectacularly failed...
2014: Future Neurology
https://read.qxmd.com/read/25309132/regional-variability-in-alzheimer-s-disease-biomarkers
#27
JOURNAL ARTICLE
Brian A Gordon, Tyler Blazey, Tammie Ls Benzinger
No abstract text is available yet for this article.
2014: Future Neurology
https://read.qxmd.com/read/24778576/migraine-and-obesity-moving-beyond-bmi
#28
Ana Recober, B Lee Peterlin
No abstract text is available yet for this article.
January 1, 2014: Future Neurology
https://read.qxmd.com/read/24678267/axonal-tract-tracing-for-delineating-interacting-brain-regions-implications-for-alzheimer-s-disease-associated-memory
#29
Thomas van Groen, Pasi Miettinen, Inga Kadish
We are studying the projections from the entorhinal cortex to the hippocampal formation in the mouse. The dentate gyrus is innervated by the lateral entorhinal cortex (lateral perforant path) and medial entorhinal cortex (medial perforant path). The entorhinal cortex also projects to hippocampal areas CA3 and CA1, and to the subiculum. In young transgenic Alzheimer's disease mouse models (before amyloid-β pathology), the connections are not different from normal mice. In Alzheimer's disease mice with pathology, two changes occur: first, dystrophic axon endings appear near amyloid-β plaques, and second, there are sparse aberrant axon terminations not in the appropriate area or lamina of the hippocampus...
January 1, 2014: Future Neurology
https://read.qxmd.com/read/24648831/neurodegeneration-in-spinal-muscular-atrophy-from-disease-phenotype-and-animal-models-to-therapeutic-strategies-and-beyond
#30
JOURNAL ARTICLE
Umrao R Monani, Darryl C De Vivo
Of the numerous inherited diseases known to afflict the pediatric population, spinal muscular atrophy (SMA) is among the most common. It has an incidence of approximately one in 10,000 newborns and a carrier frequency of one in 50. Despite its relatively high incidence, SMA remains somewhat obscure among the many neurodegenerative diseases that affect humans. Nevertheless, the last two decades have witnessed remarkable progress in our understanding of the pathology, underlying biology and especially the molecular genetics of SMA...
January 1, 2014: Future Neurology
https://read.qxmd.com/read/24489483/molecular-contributions-to-neurovascular-unit-dysfunctions-after-brain-injuries-lessons-for-target-specific-drug-development
#31
Amandine Jullienne, Jérôme Badaut
The revised 'expanded' neurovascular unit (eNVU) is a physiological and functional unit encompassing endothelial cells, pericytes, smooth muscle cells, astrocytes and neurons. Ischemic stroke and traumatic brain injury are acute brain injuries directly affecting the eNVU with secondary damage, such as blood-brain barrier (BBB) disruption, edema formation and hypoperfusion. BBB dysfunctions are observed at an early postinjury time point, and are associated with eNVU activation of proteases, such as tissue plasminogen activator and matrix metalloproteinases...
November 1, 2013: Future Neurology
https://read.qxmd.com/read/24376373/inflammation-and-human-cerebral-aneurysms-current-and-future-treatment-prospects
#32
Joseph S Hudson, Danielle S Hoyne, David M Hasan
The formation of cerebral aneurysms and their rupture propensity is of immediate clinical importance. Current management includes observation with expectant management, microsurgical clipping and/or endovascular coiling. The surgical options are invasive and are not without increased risk despite the technological advances. Recent human and animal studies have shown that inflammation plays a critical role in aneurysm formation and progression to rupture. Modulating this inflammatory process may prove to be clinically significant...
November 1, 2013: Future Neurology
https://read.qxmd.com/read/24489482/diffusion-tensor-imaging-and-related-techniques-in-tuberous-sclerosis-complex-review-and-future-directions
#33
Jurriaan M Peters, Maxime Taquet, Anna K Prohl, Benoit Scherrer, Agnies M van Eeghen, Sanjay P Prabhu, Mustafa Sahin, Simon K Warfield
In this article, the authors aim to introduce the nonradiologist to diffusion tensor imaging (DTI) and its applications to both clinical and research aspects of tuberous sclerosis complex. Tuberous sclerosis complex is a genetic neurocutaneous syndrome with variable and unpredictable neurological comorbidity that includes refractory epilepsy, intellectual disability, behavioral abnormalities and autism spectrum disorder. DTI is a method for modeling water diffusion in tissue and can noninvasively characterize microstructural properties of the brain...
September 2013: Future Neurology
https://read.qxmd.com/read/24489481/neuronal-adhesion-and-synapse-organization-in-recovery-after-brain-injury
#34
Kellie Park, Thomas Biederer
Few specific therapeutic targets exist to manage brain injury, despite the prevalence of stroke or traumatic brain injury. With traumatic brain injury, characteristic neuronal changes include axonal swelling and degeneration, and the loss of synapses, the sites of communication between neurons. This is followed by axonal sprouting and alterations in synaptic markers in recovery. The resulting changes in neuronal connectivity are likely to contribute to the effects of traumatic brain injury on cognitive functions and the underlying mechanisms may represent points of therapeutic intervention...
September 2013: Future Neurology
https://read.qxmd.com/read/24376372/in-vivo-astrocytic-ca-2-signaling-in-health-and-brain-disorders
#35
Shinghua Ding
Astrocytes are the predominant glial cell type in the CNS. Although astrocytes are electrically nonexcitable, their excitability is manifested by their Ca(2+) signaling, which serves as a mediator of neuron-glia bidirectional interactions via tripartite synapses. Studies from in vivo two-photon imaging indicate that in healthy animals, the properties of spontaneous astrocytic Ca(2+) signaling are affected by animal species, age, wakefulness and the location of astrocytes in the brain. Intercellular Ca(2+) waves in astrocytes can be evoked by a variety of stimulations...
September 1, 2013: Future Neurology
https://read.qxmd.com/read/24273459/therapy-development-for-neuromuscular-diseases-translating-hope-into-promise
#36
JOURNAL ARTICLE
Carmen Bertoni
The Second Muscular Dystrophy Association Scientific Meeting was held on 21-24 April 2013 in Washington (DC, USA). The meeting provided an opportunity for research scientists, clinicians, government agencies and industry experts to highlight and discuss different aspects of therapy development for neuromuscular diseases, including novel targets, biomarkers, therapeutic approaches, animal models and clinical trials. With 500 participants, 66 presentations and 200 abstracts, the 3-day conference has become a central focus for scientists interested in translational research and moving potential therapies forward from the bench to the bedside...
July 1, 2013: Future Neurology
https://read.qxmd.com/read/23882162/advances-in-the-treatment-of-visual-hallucinations-in-neurodegenerative-diseases
#37
JOURNAL ARTICLE
Daniel Collerton, John-Paul Taylor
Treatment of visual hallucinations in neurodegenerative disorders is not well advanced. The complexity of underlying mechanisms presents a number of potential avenues for developing treatments, but also suggests that any single one may be of limited efficacy. Reducing medication, with the careful introduction of antidementia medication if needed, is the mainstay of current management. Antipsychotic medication leads to excessive morbidity and mortality and should only be used in cases of high distress that do not otherwise respond...
July 2013: Future Neurology
https://read.qxmd.com/read/24198718/understanding-the-neurobiology-of-cd200-and-the-cd200-receptor-a-therapeutic-target-for-controlling-inflammation-in-human-brains
#38
JOURNAL ARTICLE
Douglas G Walker, Lih-Fen Lue
CD200 and its receptor, CD200 receptor (CD200R), have uniaue roles in controlling damaging inflammatory processes. At present, the only identified function for CD200 is as a ligand for CD200R. These proteins interact resulting in the activation of anti-inflammatory signaling by CD200R-expressing cells. When this interaction becomes deficient with aging or disease, chronic inflammation occurs, Experimental animal studies have demonstrated the consequences of disrupting CD200-CD200R interactions in the brain, but there have been few studies in human brains...
May 2013: Future Neurology
https://read.qxmd.com/read/23658503/astroglia-in-neurological-diseases
#39
Alexei Verkhratsky, José J Rodríguez, Vladimir Parpura
Astroglia encompass a subset of versatile glial cells that fulfill a major homeostatic role in the mammalian brain. Since any brain disease results from failure in brain homeostasis, astroglial cells are involved in many, if not all, aspects of neurological and/or psychiatric disorders. In this article, the roles of astrocytes as homeostatic cells in healthy and diseased brains are surveyed. These cells can mount the defence response to the insult of the brain, astrogliosis, when and where they display hypertrophy...
March 1, 2013: Future Neurology
https://read.qxmd.com/read/23565051/advances-in-the-cell-based-treatment-of-neonatal-hypoxic-ischemic-brain-injury
#40
Mibel M Pabon, Cesar V Borlongan
Stem cell therapy for adult stroke has reached limited clinical trials. Here, we provide translational research guidance on stem cell therapy for neonatal hypoxic-ischemic brain injury requiring a careful consideration of clinically relevant animal models, feasible stem cell sources, and validated safety and efficacy endpoint assays, as well as a general understanding of modes of action of this cellular therapy. To this end, we refer to existing translational guidelines, in particular the recommendations outlined in the consortium of academicians, industry partners and regulators called Stem cell Therapeutics as an Emerging Paradigm for Stroke or STEPS...
March 1, 2013: Future Neurology
journal
journal
41394
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.